Author : Hugh Cameron
Publisher : Xlibris Corporation
Page : 170 pages
File Size : 26,75 MB
Release : 2023-09-27
Category : Fiction
ISBN :
The information about the book is not available as of the moment.
Author : Robin Feldman
Publisher : Cambridge University Press
Page : 165 pages
File Size : 22,57 MB
Release : 2017-06-09
Category : Law
ISBN : 131673949X
While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs.
Author : Gerald Posner
Publisher : Simon and Schuster
Page : 816 pages
File Size : 45,61 MB
Release : 2020-03-10
Category : Business & Economics
ISBN : 1501152041
Award-winning journalist and New York Times bestselling author Gerald Posner reveals the heroes and villains of the trillion-dollar-a-year pharmaceutical industry and delivers “a withering and encyclopedic indictment of a drug industry that often seems to prioritize profits over patients (The New York Times Book Review). Pharmaceutical breakthroughs such as antibiotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry. “Gerald’s dogged reporting, sets Pharma apart from all books on this subject” (The Washington Standard) as we are introduced to brilliant scientists, incorruptible government regulators, and brave whistleblowers facing off against company executives often blinded by greed. A business that profits from treating ills can create far deadlier problems than it cures. Addictive products are part of the industry’s DNA, from the days when corner drugstores sold morphine, heroin, and cocaine, to the past two decades of dangerously overprescribed opioids. Pharma also uncovers the real story of the Sacklers, the family that became one of America’s wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the center of the opioid crisis. Relying on thousands of pages of government and corporate archives, dozens of hours of interviews with insiders, and previously classified FBI files, Posner exposes the secrets of the Sacklers’ rise to power—revelations that have long been buried under a byzantine web of interlocking companies with ever-changing names and hidden owners. The unexpected twists and turns of the Sackler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. “Explosively, even addictively, readable” (Booklist, starred review), Pharma reveals how and why American drug companies have put earnings ahead of patients.
Author : Murphy Halliburton
Publisher : Cornell University Press
Page : 241 pages
File Size : 27,30 MB
Release : 2017-11-15
Category : Social Science
ISBN : 1501713981
India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over these processes. Murphy Halliburton contributes to analyses of globalization within the fields of anthropology, sociology, law, and public health by drawing on interviews and ethnographic work with pharmaceutical producers in India and the United States. India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India’s largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward.
Author : David Herzberg
Publisher : University of Chicago Press
Page : 372 pages
File Size : 28,4 MB
Release : 2020-10-23
Category : History
ISBN : 022673191X
The contemporary opioid crisis is widely seen as new and unprecedented. Not so. It is merely the latest in a long series of drug crises stretching back over a century. In White Market Drugs, David Herzberg explores these crises and the drugs that fueled them, from Bayer’s Heroin to Purdue’s OxyContin and all the drugs in between: barbiturate “goof balls,” amphetamine “thrill pills,” the “love drug” Quaalude, and more. As Herzberg argues, the vast majority of American experiences with drugs and addiction have taken place within what he calls “white markets,” where legal drugs called medicines are sold to a largely white clientele. These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its “drug wars”—until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America’s divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets to minimize risks while maintaining safe, reliable access (and treatment) for people with addiction. Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century. By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself—ideas that have been failing us catastrophically for over a century.
Author : Benjamin Lessing
Publisher : Cambridge University Press
Page : 357 pages
File Size : 29,33 MB
Release : 2018
Category : History
ISBN : 1107199638
State crackdowns on drug cartels often backfire, producing entrenched 'cartel-state conflict'; deterrence approaches have curbed violence but proven fragile. This book explains why.
Author : Carl Boggs
Publisher : Routledge
Page : 268 pages
File Size : 26,41 MB
Release : 2015-12-03
Category : Political Science
ISBN : 1317260945
This book explores the increasingly broad terrain of drugs in American society with an emphasis on politics. It begins with the War on Drugs initiated by President Richard Nixon in the early 1970s and extends to the current day with the vast power of the pharmaceutical industry (Big Pharma), expansion of global criminal syndicates, militarization of the drug war, and struggles between states and federal government over the legalization of marijuana. From the beginning, the drug war produced increasing authoritarian tendencies in American politics, visible not only in swollen national bureaucracies and burgeoning police functions, but in the rise of the largest prison-industrial complex in the world, a surveillance state, and the weakening of personal privacy and freedoms. At the same time, the legal drug system with some of the most profitable business operations anywhere has expanded to create a huge medical edifice, affecting the delivery of health care, development of modern psychology, evolution of the treatment industry, and many other areas of contemporary life, including the world of sports and recreation. Although prohibitionism remains very much alive, targeting a wide range of illicit drugs, today it is the hundreds of widely-marketed chemical substances sold by Big Pharma that result in some of the most serious health problems affecting society. This book explores the long historical trajectory of both the War on Drugs and the growth of Big Pharma, focusing on social outcomes and political consequences in the US and beyond.
Author : Kathleen Frydl
Publisher : Cambridge University Press
Page : 459 pages
File Size : 36,57 MB
Release : 2013-04-30
Category : History
ISBN : 1107013909
Examines how and why the US government went from regulating illicit drug traffic and consumption to declaring war on both.
Author : Ben Goldacre
Publisher : Macmillan
Page : 479 pages
File Size : 36,37 MB
Release : 2014-04
Category : Business & Economics
ISBN : 0865478066
Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.
Author : Dominique A. Tobbell
Publisher : Univ of California Press
Page : 310 pages
File Size : 25,78 MB
Release : 2012
Category : Business & Economics
ISBN : 0520271130
"Tobbell analyzes the political and economic history of the alignment of the pharmaceutical industry, academic institutions and their faculty and organized medicine. This book is essential reading for policymakers and their staff as well as persons who study the history of health policy and those who contribute to it through medical research, advocacy and journalism. " -Daniel Fox, author of The Convergence of Science and Governance: Research, Health Policy, and American States "Dominique Tobbell’s vivid, balanced and probing account of pharmaceutical politics is a significant, needed analysis of the relationships between the pharmaceutical industry, university researchers, the medical profession and government in the Cold War period. More than this, Pills, Power, and Policy shows why it continues to be difficult to agree in the United States on the relative roles of corporate enterprise, government regulation, technological innovation, freedom to prescribe, and consumer marketing and protection, all played out against the rising costs of health care. Timely and thought-provoking."--Rosemary A. Stevens. DeWitt Wallace Distinguished Scholar, Department of Psychiatry, Weill Cornell Medical College "A superb and compelling account of the creation of one of America’s most reviled entities: Big Pharma. With clarity and subtlety, Pills, Power, and Policy weaves together the political, economic, and the medical to reveal the entangled history behind our modern pharmaceutical predicament."--Andrea Tone, Ph.D., Professor of History & Canada Research Chair in the Social History of Medicine, McGill University “Pills, Power and Policy provides an outstanding description and analysis of the evolution of drug policy. It is an extremely important contribution to our understanding of the political, scientific, and economic nature of pharmaceutical regulation." -Daniel S. Greenberg, Washington journalist and author of Science, Money and Politics: Political Triumph and Ethical Erosion
